These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 2465745

  • 1. [Biological activity of human alpha-interferons studied using specific antisera].
    Korsun NS, Nosik DN, Novokhatskiĭ AS, Trushinskaia GN.
    Antibiot Khimioter; 1988 Nov; 33(11):827-30. PubMed ID: 2465745
    [Abstract] [Full Text] [Related]

  • 2. Antigenic structure of human interferon omega 1 (interferon alpha II1): comparison with other human interferons.
    Adolf GR.
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1669-76. PubMed ID: 2438379
    [Abstract] [Full Text] [Related]

  • 3. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
    Ozes ON, Reiter Z, Klein S, Blatt LM, Taylor MW.
    J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes.
    Lee SH, Kelley S, Chiu H, Stebbing N.
    Cancer Res; 1982 Apr; 42(4):1312-6. PubMed ID: 6174222
    [Abstract] [Full Text] [Related]

  • 5. Are the acid-labile interferon alpha and interferon omega-1 identical?
    Kontsek P, Borecký L, Novák M.
    Virology; 1991 Mar; 181(1):416-8. PubMed ID: 1994590
    [Abstract] [Full Text] [Related]

  • 6. [Comparative study of the biological properties of plasmid and natural human interferons].
    Ovchinnikov IuA, Zhdanov VM, Solov'ev VD, Novokhatskiĭ AS, Aspetov RD.
    Vopr Virusol; 1983 Mar; 28(1):14-21. PubMed ID: 6189294
    [Abstract] [Full Text] [Related]

  • 7. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
    Redlich PN, Grossberg SE.
    J Immunol; 1989 Sep 15; 143(6):1887-93. PubMed ID: 2476486
    [Abstract] [Full Text] [Related]

  • 8. Some biological activities of rabbit anti-interferon serum.
    Fuchsberger N, Styk B, Borecký L, Hajnická V.
    Acta Virol; 1976 Apr 15; 20(2):107-13. PubMed ID: 5864
    [Abstract] [Full Text] [Related]

  • 9. Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).
    Langford MP, Weigent DA, Georgiades JA, Johnson HM, Stanton GJ.
    J Immunol; 1981 Apr 15; 126(4):1620-3. PubMed ID: 6162895
    [Abstract] [Full Text] [Related]

  • 10. [Simple method of determining the antiproliferative activity of human interferons].
    Aspetov RD, Shaĭkhinova TB, Novokhatskiĭ AS, Shuratov IKh.
    Antibiot Med Biotekhnol; 1985 Mar 15; 30(3):204-8. PubMed ID: 2409914
    [Abstract] [Full Text] [Related]

  • 11. The reaction of the anti-interferon-alpha monoclonal antibody, NK2, with different interferons.
    Whittall JT, King RM, Burke DC.
    J Gen Virol; 1984 Mar 15; 65 ( Pt 3)():629-33. PubMed ID: 6199457
    [Abstract] [Full Text] [Related]

  • 12. Novel modified beta-interferons: gene cloning, expression, and biological activity in bacterial extracts.
    Porter AG, Bell LD, Adair J, Catlin GH, Clarke J, Davies JA, Dawson K, Derbyshire R, Doel SM, Dunthorne L.
    DNA; 1986 Apr 15; 5(2):137-48. PubMed ID: 3519136
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the neutralizing properties of monoclonal and polyclonal antibodies to human interferon alpha.
    Exley T, Parti S, Barwick S, Meager A.
    J Gen Virol; 1984 Dec 15; 65 ( Pt 12)():2277-80. PubMed ID: 6512507
    [Abstract] [Full Text] [Related]

  • 14. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
    Losinno C, Wines BD, Johns TG, Mackay IR.
    Nat Immun; 1992 Dec 15; 11(4):215-24. PubMed ID: 1384830
    [Abstract] [Full Text] [Related]

  • 15. [Antitoxic activity of interferon preparations].
    Zueva VS, Pashutin SB, Kuznetsov VP, Spivak NIa, Korobko IV.
    Antibiot Med Biotekhnol; 1985 Sep 15; 30(9):665-8. PubMed ID: 2415059
    [Abstract] [Full Text] [Related]

  • 16. [Physicochemical and biological properties of human placental amniotic interferon].
    Bakhutashvili VI, Merabishvili DG, Gogitashvili RV, Korsantiia BM, Dzotsenidze LL.
    Vopr Virusol; 1985 Sep 15; 30(6):693-7. PubMed ID: 2420070
    [Abstract] [Full Text] [Related]

  • 17. Comparative antiproliferative and receptor binding activities of interferons alpha and beta on lymphoblastoid and melanoma cells.
    Hertzog PJ, Johns TG, Callister KA, Dinatale A, Linnane AW.
    Biochem Int; 1990 Dec 15; 22(6):1095-102. PubMed ID: 2151021
    [Abstract] [Full Text] [Related]

  • 18. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS, Hawkins MJ, Borden EC.
    Cancer Res; 1984 Jul 15; 44(7):3135-9. PubMed ID: 6586292
    [Abstract] [Full Text] [Related]

  • 19. Porcine leukocyte interferon exhibits close antigenic relatedness to human interferon alpha 2, but not to human interferon alpha 1.
    Karayianni-Vasconcelos G, Borecký L, Kontsek P.
    Vet Immunol Immunopathol; 1993 Oct 15; 38(3-4):359-65. PubMed ID: 7507275
    [Abstract] [Full Text] [Related]

  • 20. Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations.
    Antonelli G, Currenti M, Turriziani O, Dianzani F.
    J Infect Dis; 1991 Apr 15; 163(4):882-5. PubMed ID: 1901335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.